The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Open accessAbstract
BACKGROUND: The incidence and severity of herpes zoster and postherpetic neuralgia increase with age in association with a progressive decline in cell-mediated immunity to varicella-zoster virus (VZV). We tested the hypothesis that vaccination against VZV would decrease the incidence, severity, or both of herpes zoster and postherpetic neuralgia among older adults. METHODS: We enrolled 38,546 adults 60 years of age or older in a randomized, double-blind, placebo-controlled trial of an investigational live attenuated Oka/Merck VZV vaccine ("zoster vaccine"). Herpes zoster was diagnosed according to clinical and laboratory criteria. The pain and discomfort associated with herpes zoster were measured repeatedly for six months. The primary end point was the burden of illness due to herpes zoster, a measure affected by the incidence, severity, and duration of the associated pain and discomfort. The secondary end point was the incidence of postherpetic neuralgia. RESULTS: More than 95 percent of the subjects continued in the study to its completion, with a median of 3.12 years of surveillance for herpes zoster. A total of 957 confirmed cases of herpes zoster (315 among vaccine recipients and 642 among placebo recipients) and 107 cases of postherpetic neuralgia (27 among vaccine recipients and 80 among placebo recipients) were included in the efficacy analysis. The use of the zoster vaccine reduced the burden of illness due to herpes zoster by 61.1 percent (P<0.001), reduced the incidence of postherpetic neuralgia by 66.5 percent (P<0.001), and reduced the incidence of herpes zoster by 51.3 percent (P<0.001). Reactions at the injection site were more frequent among vaccine recipients but were generally mild. CONCLUSIONS: The zoster vaccine markedly reduced morbidity from herpes zoster and postherpetic neuralgia among older adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A live-attenuated vaccine is available, which has been shown to reduce the incidence of herpes zoster by 51.3% (95% CI: 44.2–57.6) and of post-herpetic neuralgia, a severe complication occurring frequently in the elderly, by 66.5% (95% CI: 44.5–79.2) in the vaccinated population compared to placebo [170].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [170]
In the citing paper
“The protective effect against post-herpetic neuralgia was independent of age, whereas clinical efficacy against herpes zoster declined to only 27.6% in persons older than 69 years.”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [170]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases
Daut, R. L., Cleeland, C. S., & Flanery, R. C. (1983) · Pain · doi:10.1016/0304-3959(83)90143-4 · Cited by 1,562
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,389
Comparative analysis of two rates
Miettinen, O. S., & Nurminen, M. M. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040211 · Cited by 1,111
Population-Based Study of Herpes Zoster and Its Sequelae
Ragozzino, M. W., Melton, L. J., Kurland, L. T., CHU, C. P., & PERRY, H. O. (1982) · Medicine · doi:10.1097/00005792-198209000-00003 · Cited by 921
Gnann, J. W., & Whitley, R. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013211 · Cited by 781
Self-citationTesting the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire
Brazier, J. E., Jones, N., & Kind, P. (1993) · Quality of Life Research · doi:10.1007/bf00435221 · Cited by 707
Postherpetic Neuralgia — Pathogenesis, Treatment, and Prevention
Kost, R. G., & Straus, S. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350107 · Cited by 641
Self-citationThe Incidence of Herpes Zoster
Donahue, J. G. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430150071008 · Cited by 618
Research works printed but not linked: 2
- Hope-Simpson RE, 1965, Proc R Soc Med, 58, 9
- Hope-Simpson RE, 1975, J R Coll Gen Pract, 25, 571
Cited by
Sorted by citations
Items 601–700 of 1,001
Calabrese, L. H., Abud‐Mendoza, C., Lindsey, S. M., Lee, S., Tatulych, S., Takiya, L., Iikuni, N., Soma, K., Luo, Z., & Fleischmann, R. (2019) · Arthritis Care & Research · doi:10.1002/acr.24010 · Cited by 39
Diabetes as a risk factor for herpes zoster in adults: A synthetic literature review
Saadatian‐Elahi, M., Bauduceau, B., Signore, C. D., & Vanhems, P. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107983 · Cited by 39
The Biology of Varicella-Zoster Virus Replication in the Skin
Tommasi, C., & Breuer, J. (2022) · Viruses · doi:10.3390/v14050982 · Cited by 41
Vaccines for preventing herpes zoster in older adults
Gomes, J. D. O., Gagliardi, A. M., Andriolo, B. N., Torloni, M. R., Andriolo, R. B., Puga, M. E. D. S., & Cruz, E. C. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008858.pub5 · Cited by 42
Herpes virus infection of the peripheral nervous system
Steiner, I. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52902-2.00031-x · Cited by 39
Vaccination to Prevent Herpes Zoster in Older Adults
Gnann, J. W. (2008) · Journal of Pain · doi:10.1016/j.jpain.2007.10.007 · Cited by 39
Self-citationProspects of vaccines for medically important fungi
Feldmesser, M. (2005) · Medical Mycology · doi:10.1080/13693780500402138 · Cited by 39
Varicella vaccination in Australia
Macartney, K. K., Beutels, P., McIntyre, P. B., & Burgess, M. (2005) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2005.00717.x · Cited by 39
Persistent and Recurring Viral Infections: The Human Herpesviruses
Schleiss, M. R. (2008) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2008.10.003 · Cited by 39
Health Care Expenditure Burden of Persisting Herpes Zoster Pain
Dworkin, R. H., White, R., O'connor, A., & Hawkins, K. (2007) · Pain Medicine · doi:10.1111/j.1526-4637.2006.00196.x · Cited by 39
Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
Safonova, E., Yawn, B. P., Welte, T., & Wang, C. (2023) · Respiratory Research · doi:10.1186/s12931-022-02305-1 · Cited by 38
Giannelos, N., Ng, C., & Curran, D. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2168952 · Cited by 38
Evidence-based Guidance for the Management of Postherpetic Neuralgia in Primary Care
Harden, R. N., Kaye, A. D., Kintanar, T., & Argoff, C. E. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.07.2690 · Cited by 38
Bresse, X., Annemans, L., Preaud, E., Bloch, K., Duru, G., & Gauthier, A. (2013) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.13.19 · Cited by 38
Safety of Zostavax™—A cohort study in a managed care organization
Baxter, R. P., Tran, T. N., Hansen, J. R., Emery, M., FIREMAN, B. H., Bartlett, J., Lewis, N., & Saddier, P. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.08.070 · Cited by 38
Pickering, G. P., Gavazzi, G., Gaillat, J., Paccalin, M., Bloch, K., & Bouhassira, D. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009689 · Cited by 38
Herpes zoster: Risk and prevention during immunomodulating therapy
Tran, C. T., Ducancelle, A., Masson, C., & Lunel, F. (2016) · Joint Bone Spine · doi:10.1016/j.jbspin.2016.04.001 · Cited by 38
Risk and impact of herpes zoster among COPD patients: a population-based study, 2009–2014
Muñoz-Quiles, C., López‐Lacort, M., & Díez‐Domingo, J. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3121-x · Cited by 38
Recommendations and barriers to vaccination in systemic lupus erythematosus
Garg, M., Mufti, N., Palmore, T. N., & Hasni, S. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.04.006 · Cited by 41
Animal Models of Varicella Zoster Virus Infection
Haberthur, K., & Messaoudi, I. (2013) · Pathogens · doi:10.3390/pathogens2020364 · Cited by 39
Hospitalizations to Treat Herpes Zoster in Older Adults: Causes and Validated Rates
Jackson, L. A., Reynolds, M. A., & Harpaz, R. (2008) · Clinical Infectious Diseases · doi:10.1086/591132 · Cited by 38
Corticosteroid Use and Risk of Herpes Zoster in a Population-Based Cohort
Qian, J., Banks, E., Macartney, K. K., Heywood, A. E., Lassere, M. N., & Liu, B. C. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.05.029 · Cited by 37
Varicella zoster vaccines and their implications for development of HSV vaccines
Gershon, A. A. (2012) · Virology · doi:10.1016/j.virol.2012.10.006 · Cited by 39
Self-citationBenzon, H. T., Chekka, K. K., Darnule, A., Chung, B., Wille, O., & Malik, K. M. (2009) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0b013e3181b137bd · Cited by 37
Varicella-Zoster Virus–Specific Antibody Responses in 50–59-Year-Old Recipients of Zoster Vaccine
Levin, M. J., Schmader, K. E., Gnann, J. W., McNeil, S., Vesikari, T., Betts, R. F., Keay, S. K., Stek, J. E., Bundick, N. D., Su, S., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit342 · Cited by 37
Self-citationPentikis, H. S., Matson, M., Atiee, G. J., Boehlecke, B. A., Hutchins, J. T., Patti, J. M., Henson, G. W., & Morris, A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01446-10 · Cited by 37
Valente, N., Lupi, S., Stefanati, A., Cova, M., Sulcaj, N., Piccinni, L., GPs Study Group, & Gabutti, G. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011539 · Cited by 37
Pandit, A., Leblebjian, H., Hammond, S. P., Laubach, J. P., Richardson, P. G. G., Baden, L. R., Marty, F. M., & Issa, N. C. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0112-x · Cited by 37
Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention
Klein, N. P., Bartlett, J., FIREMAN, B. H., Marks, M. A., Hansen, J. R., Lewis, E. M., Aukes, L. L., & Saddier, P. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.07.004 · Cited by 37
Mullane, K. M., Morrison, V. A., Camacho, L. H., Arvin, A. M., McNeil, S., Hall, J. D., Campbell, B., Su, S., Chan, I. S. F., Parrino, J., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30310-x · Cited by 37
Self-citationSafety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease
Satyam, V. R., Li, P., Reich, J. S., Qazi, T., Noronha, A. M., Wasan, S. K., & Farraye, F. A. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-06016-4 · Cited by 37
Gershon, A. A., Levin, M. J., Weinberg, A., Song, L.-Y., LaRussa, P. S., Steinberg, S. P., & Bartlett, P. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181998f06 · Cited by 37
Self-citationSixteen Years of Global Experience with the First Refrigerator-Stable Varicella Vaccine (Varilrix™)
Kreth, H. W., Lee, B.-W., Kosuwon, P., Salazar, J., Barzaga, N. G., Bock, H. L., & Meurice, F. (2008) · BioDrugs · doi:10.2165/0063030-200822060-00005 · Cited by 37
A community-based survey of varicella-zoster virus-specific immune responses in the elderly
Tang, H., Moriishi, E., Okamoto, S., Okuno, Y., Iso, H., Asada, H., Yamanishi, K., & Mori, Y. (2012) · Journal of Clinical Virology · doi:10.1016/j.jcv.2012.06.008 · Cited by 37
Prelog, M., Schönlaub, J., Jeller, V., Almanzar, G., Höfner, K., Gruber, S., Eiwegger, T., & Würzner, R. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.03.058 · Cited by 37
A Short History of Vaccination
Plotkin, S. L., & Plotkin, S. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00001-3 · Cited by 43
Maréchal, C., Lal, H., Poder, A., Ferguson, M., Enweonye, I., Heineman, T. C., Hervé, C., Rheault, P., Talli, J., Wauters, D., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.05.110 · Cited by 36
The effect of shingles vaccination at different stages of the dementia disease course
Xie, M., Eyting, M., Bommer, C., Ahmed, H., & Geldsetzer, P. (2025) · Cell · doi:10.1016/j.cell.2025.11.007 · Cited by 40
Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands
de Boer, P. T., Pouwels, K. B., Cox, J. M., Hak, E., Wilschut, J., & Postma, M. J. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.12.067 · Cited by 36
Russell, A. F., Parrino, J., Fisher, C., Spieler, W., Stek, J. E., Coll, K. E., Su, S., Xu, J. Z., Li, X., Schlienger, K., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.090 · Cited by 36
Self-citationVaccinology in the third millennium: scientific and social challenges
Poland, G. A., Whitaker, J. A., Poland, C. M., Ovsyannikova, I. G., & Kennedy, R. B. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.03.003 · Cited by 36
The positive duration of varicella zoster immunoglobulin M antibody test in herpes zoster
Min, S.-W., Kim, Y. S., Nahm, F. S., Yoo, D. H., Choi, E., Lee, P. B., Choo, H., Park, Z., & Yang, C. S. (2016) · Medicine · doi:10.1097/md.0000000000004616 · Cited by 36
National and State-Specific Shingles Vaccination Among Adults Aged ≥60 Years
Lu, P.-J., O’Halloran, A. C., Williams, W. W., & Harpaz, R. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.08.031 · Cited by 36
Opportunistic Infections in Biological Therapy, Risk and Prevention
Bryant, P. A., & Baddley, J. W. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2016.09.005 · Cited by 36
Vaccine profile of herpes zoster (HZ/su) subunit vaccine
Cunningham, A. L., & Heineman, T. C. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1329012 · Cited by 36
Lam, A. C., Chan, M., Chou, H., Ho, S. Y., Li, H., Lo, C., Shek, K., To, S., Yam, K., & Yeung, I. (2017) · Hong Kong Medical Journal · doi:10.12809/hkmj165043 · Cited by 36
Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review
Chiyaka, E. T., Nghiem, V. T. H., Zhang, L., Deshpande, A., Mullen, P. D., & Le, P. (2018) · PharmacoEconomics · doi:10.1007/s40273-018-0735-1 · Cited by 36
Wui, S. R., Kim, K. S., Ryu, J. I., Ko, A., Do, H. T. T., Lee, Y. J., Kim, H. J., Lim, S. J., Park, S. A., Cho, Y. J., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.02.048 · Cited by 36
Braun, D. C., Birch, A. C., Benson, D. B., Stein, R. F., & Nordlund, Å. (2007) · The Astrophysical Journal · doi:10.1086/521782 · Cited by 36
Herpes simplex virus, varicella-zoster virus and cytomegalovirus keratitis: Facts for the clinician
Labétoulle, M., Boutolleau, D., Burrel, S., Haigh, O. L., & Rousseau, A. (2021) · The Ocular Surface · doi:10.1016/j.jtos.2021.07.002 · Cited by 36
Therapeutic vaccination to treat chronic infectious diseases
Boukhebza, H., Bellon, N., Limacher, J. M., & Inchauspé, G. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.21689 · Cited by 36
Zumbrun, E. E., Wang, F., Lubinski, J. M., Bunte, R. M., & Friedman, H. M. (2008) · Journal of Virology · doi:10.1128/jvi.00551-08 · Cited by 36
HIV-1 Variable Loop 2 and its Importance in HIV-1 Infection and Vaccine Development
Rao, M., Peachman, K. K., Kim, J., Gao, G., Alving, C. R., Michael, N. L., & Rao, V. B. (2013) · Current HIV Research · doi:10.2174/1570162x113116660064 · Cited by 36
Cohrs, R. J., Gilden, D. H., Gomi, Y., Yamanishi, K., & Cohen, J. I. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2076-2082.2006 · Cited by 36
Efficacy and safety of the recombinant zoster vaccine: A systematic review and meta-analysis
Zeevaert, R., Thiry, N., de Noordhout, C. M., & Roberfroid, D. (2023) · Vaccine X · doi:10.1016/j.jvacx.2023.100397 · Cited by 35
Vaccination for preventing postherpetic neuralgia
Chen, N., Li, Q., Zhang, Y., Zhou, M., Zhou, D., & He, L. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007795.pub2 · Cited by 35
Szucs, T. D., Kressig, R. W., Papageorgiou, M., Kempf, W., Michel, J., Fendl, A., & Bresse, X. (2011) · Human Vaccines · doi:10.4161/hv.7.7.15573 · Cited by 35
Advocating Vaccination of Adults Aged 60 Years and Older in Western Europe:
Michel, J., Chidiac, C., Grubeck‐Loebenstein, B., Johnson, R. W., Lambert, P. H., Maggi, S., Moulias, R., Nicholson, K. G., & Werner, H. (2009) · Rejuvenation Research · doi:10.1089/rej.2008.0813 · Cited by 35
Ultsch, B., Weidemann, F., Reinhold, T., Siedler, A., Krause, G., & Wichmann, O. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-359 · Cited by 35
Reid, G., Lynch, J. P., Weigt, S., Sayah, D. M., Belperio, J. A., Grim, S. A., & Clark, N. M. (2016) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0036-1584793 · Cited by 36
Bhattacharya, P., Dey, R., Dagur, P. K., Joshi, A. B., Ismail, N., Gannavaram, S., Debrabant, A., Akue, A. D., KuKuruga, M. A., Selvapandiyan, A., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004963 · Cited by 34
Focusing on the implementation of 21st century vaccines for adults
Bonanni, P., Bonaccorsi, G., Lorini, C., Santomauro, F., Tiscione, E., Boccalini, S., & Bechini, A. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.100 · Cited by 36
Nordén, R., Nilsson, J., Samuelsson, E., Risinger, C., Sihlbom, C., Blixt, O., Larson, G., Olofsson, S., & Bergström, T. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040954 · Cited by 35
Understanding the immunology of the Zostavax shingles vaccine
Sullivan, N., Eberhardt, C. S., Wieland, A., Vora, K. A., Pulendran, B., & Ahmed, R. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.02.005 · Cited by 35
Sun, Y., Jackson, K. E., Dalmon, C. A., Shapiro, B. L., Nie, S., Wong, C., Arnold, B. F., Porco, T. C., & Acharya, N. R. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.05.056 · Cited by 35
Ocular herpes: the pathophysiology, management and treatment of herpetic eye diseases
Zhu, L., & Zhu, H. (2014) · Virologica Sinica · doi:10.1007/s12250-014-3539-2 · Cited by 35
Immune therapy for age-related diseases
Weksler, M. E., Pawelec, G., & Franceschi, C. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.03.011 · Cited by 35
Perspectives on Vaccines Against Varicella-Zoster Virus Infections
Gershon, A. A., & Gershon, M. D. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_12 · Cited by 35
Self-citationAn Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
Meningococcal, C. (2007) · Cited by 35
Swiss recommendations for the management of varicella zoster virus infections
Agosti, R. (2007) · Swiss Medical Weekly · doi:10.4414/smw.2007.11721 · Cited by 35
Winthrop, K. L., & Fürst, D. E. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.133843 · Cited by 35
Herpes zoster vaccination in systemic lupus erythematosus: the current status
Mok, C. C. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1514228 · Cited by 35
Clinical and molecular aspects of the live attenuated Oka varicella vaccine
Quinlivan, M., & Breuer, J. (2014) · Reviews in Medical Virology · doi:10.1002/rmv.1789 · Cited by 34
Cho, S. I., Lee, C. H., Park, G., Park, C. W., & Kim, H. O. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.10.006 · Cited by 34
Factors Associated With Age of Onset of Herpes Zoster Ophthalmicus
Chan, A. Y., Conrady, C. D., Ding, K., Dvorak, J., & Stone, D. U. (2015) · Cornea · doi:10.1097/ico.0000000000000362 · Cited by 34
Systems Biology of Vaccination in the Elderly
Duraisingham, S., Rouphael, N., Cavanagh, M., Nakaya, H. I., Goronzy, J. J., & Pulendran, B. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_250 · Cited by 34
Zajkowska, A., Garkowski, A., Świerzbińska, R., Kułakowska, A., Król, M. E., Ptaszyńska-Sarosiek, I., Nowicka-Ciełuszecka, A., Pancewicz, S. A., Czupryna, P., Moniuszko-Malinowska, A. M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150301 · Cited by 34
Fochesato, M., Dendouga, N., & Boxus, M. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1154247 · Cited by 34
Natural history of herpes zoster: Late follow-up of 3.9 years (n = 43) and 7.7 years (n = 10)
Reda, H. M., Greene, K. A., Rice, F. L., Rowbotham, M. C., & Petersen, K. L. (2013) · Pain · doi:10.1016/j.pain.2013.04.015 · Cited by 34
Mick, G., Gallais, J.-L., Simón, F., Pinchinat, S., Bloch, K., Beillat, M., Serradell, L., & Derrough, T. (2010) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2010.06.166 · Cited by 34
Yun, H., Xie, F., Baddley, J. W., Winthrop, K. L., Saag, K. G., & Curtis, J. R. (2017) · The Journal of Rheumatology · doi:10.3899/jrheum.160685 · Cited by 34
The Epidemiology and Natural History of Herpes Zoster and Postherpetic Neuralgia
Schmader, K. E., & Dworkin, R. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-44348-5_4 · Cited by 34
Self-citationFeldman, A. G., Atkinson, K. M., Wilson, K. R., & Kumar, D. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15605 · Cited by 34
Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination
Johnson, R. W. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03324909 · Cited by 34
Herpes Zoster After Lung Transplantation: Incidence, Timing, and Outcome
Fuks, L., Shitrit, D., Fox, B. D., Amital, A., Raviv, Y., Bakal, I., & Kramer, M. R. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.11.004 · Cited by 33
Augustine, S., & Bonomo, R. A. (2011) · European Journal of Microbiology and Immunology · doi:10.1556/eujmi.1.2011.3.2 · Cited by 32
Dworkin, R. H., Panarites, C. J., Armstrong, E. P., Malone, D. C., & Pham, S. V. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03403.x · Cited by 33
Soh, H., Chun, J., Han, K., Park, S., Choi, G., Kim, J. H., Lee, J., Kim, J. S., & Kim, J. S. (2019) · Gut and Liver · doi:10.5009/gnl18304 · Cited by 33
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations
Gewandter, J. S., Dworkin, R. H., Turk, D. C., Farrar, J. T., Fillingim, R. B., Gilron, I., Markman, J. D., Oaklander, A. L., Polydefkis, M. J., Raja, S. N., et al. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000895 · Cited by 34
Vesikari, T., Hardt, R., Rümke, H. C., Icardi, G., Montero, J., Thomas, S., Sadorge, C., & Fiquet, A. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.23412 · Cited by 33
Vaccination in the Elderly: What Can Be Recommended?
Lang, P. O., & Aspinall, R. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0193-1 · Cited by 33
Herpes Zoster in Juvenile-Onset Systemic Lupus Erythematosus
Lee, P. P. W., Lee, T.-L., Ho, M., Wong, W. H. S., & Lau, Y. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000226841.03751.1f · Cited by 33
A Case of Diaphragmatic Paralysis Complicated by Herpes-zoster Virus Infection
Oike, M., Naito, T., Tsukada, M., Kikuchi, Y., Sakamoto, N., Otsuki, Y., Ohshima, H., Yokokawa, H., Isonuma, H., & Dambara, T. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.6935 · Cited by 33
Miller, E. R., Lewis, P., Shimabukuro, T. T., Su, J. R., Moro, P. L., Woo, E. J., Jankosky, C., & Cano, M. V. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1456598 · Cited by 33
Casadevall, A., & Pirofski, L. (2005) · Medical Mycology · doi:10.1080/13693780500448230 · Cited by 33
Impact of Biologic Agents on Infectious Diseases
Saketkoo, L. A., & Espinoza, L. R. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.09.001 · Cited by 33
Antiviral therapy of varicella-zoster virus infections
Gnann, J. W. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.066 · Cited by 32
Self-citationOuwendijk, W. J. D., Flowerdew, S. E., Wick, D., Horn, A. K. E., Sinicina, I., Strupp, M. L., Osterhaus, A. D. M. E., Verjans, G. M. G. M., & Hüfner, K. (2012) · Journal of NeuroVirology · doi:10.1007/s13365-012-0095-0 · Cited by 32
Varicella vaccination in Japan: necessity of implementing a routine vaccination program
Ozaki, T. (2013) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-013-0577-x · Cited by 32
Cuenca, A. M. C., Díez‐Domingo, J., Rodríguez, M. S.-M., Puig‐Barberà, J., & Navarro-Pérez, J. (2010) · BMC Family Practice · doi:10.1186/1471-2296-11-33 · Cited by 32
Metadata
- Authors
- Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., Weinberg, A., Boardman, K. D., Williams, H. M., Zhang, J. H., Peduzzi, P. N., Beisel, C. E., Morrison, V. A., Guatelli, J. C., Brooks, P. A., Kauffman, C. A., Pachucki, C. T., Neuzil, K. M., Betts, R. F., Wright, P. F., Griffin, M. R., Brunell, P., Soto, N. E., Marques, A. R., Keay, S. K., Goodman, R. P., Cotton, D. J., Gnann, J. W., Loutit, J., Holodniy, M., Keitel, W. A., Crawford, G. E., Yeh, S.-S., Lobo, Z., Toney, J. F., Greenberg, R. N., Keller, P. M., Harbecke, R., Hayward, A. R., Irwin, M. R., Kyriakides, T. C., Chan, C. Y., Chan, I. S. F., Wang, W. W. B., Annunziato, P. W., & Silber, J. L.
- Affiliations
- University of California San Diego (US)
- Durham VA Medical Center (US)
- Duke Medical Center (US)
- National Institutes of Health (US)
- Washington University in St. Louis (US)
- VA Boston Healthcare System (US)
- VA NY Harbor Healthcare System (US)
- Columbia University (US)
- New Mexico VA Health Care System (US)
- National Institute of Allergy and Infectious Diseases (US)
- VA San Diego Healthcare System (US)
- VA Ann Arbor Healthcare System (US)
- Edward Hines, Jr. VA Hospital (US)
- VA Puget Sound Health Care System (US)
- University of Rochester Medicine (US)
- Vanderbilt University Medical Center (US)
- Baltimore VA Medical Center (US)
- VA Palo Alto Health Care System (US)
- Baylor College of Medicine (US)
- The University of Texas at San Antonio Health Science Center (US)
- Northport VA Medical Center (US)
- James A. Haley Veterans' Hospital (US)
- Lexington VA Health Care System (US)
- University of California, Los Angeles (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-06-02
- Volume
- 352
- Issue
- 22
- Pages
- 2271-2284
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2131041950
- Cited by
- 2,412
- References
- 40
- Citations by year
- 2026: 51 · 2025: 90 · 2024: 63 · 2023: 92 · 2022: 60 · 2021: 95 · 2020: 97 · 2019: 111 · 2018: 145 · 2017: 155 · 2016: 158 · 2015: 133 · 2014: 126 · 2013: 149 · 2012: 110
- FWCI
- 89.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Office of Research and Development
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Keywords
- herpes zoster, postherpetic neuralgia, varicella-zoster virus, live attenuated zoster vaccine, older adults, vaccine efficacy, disease burden, cell-mediated immunity, injection site reactions
- MeSH terms
- Aged, Double-Blind Method, Female, Follow-Up Studies, Herpes Zoster, Humans, Immunologic Memory, Male, Middle Aged, Neuralgia, Vaccines, Attenuated, Herpesvirus 3, Human, Virus Activation, Incidence, Cost of Illness, Chickenpox Vaccine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
